[RSV versus SARS-CoV-2 in children : Comparison of hospitalised cases].

Alexandra Victoria Brey, Florian Pengg, Thomas Frischer, Angela Zacharasiewicz

Abstract readComparative StudyEnglish Abstract

In one paragraph

Article in Wiener medizinische Wochenschrift (1946), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Epidemiology of respiratory syncytial virus in a German hospital before, during and after the COVID-19 pandemic - a real world monocentric analysis over ten years.Frontiers in pediatrics · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra Victoria BreyFaculty for Medicine, Sigmund Freud Private University, Freudplatz 3, 1020, Vienna, Austria. Alexandra.brey@gmx.at.ORCID http://orcid.org/0009-0005-3243-7252

Florian PenggFaculty for Medicine, Sigmund Freud Private University, Freudplatz 3, 1020, Vienna, Austria.

Thomas FrischerFaculty for Medicine, Sigmund Freud Private University, Freudplatz 3, 1020, Vienna, Austria.

Angela ZacharasiewiczDepartment of Pediatrics and Adolescent Medicine, Klinik Ottakring, Vienna, Austria, 1160.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV‑2 and RSV are common viral pathogens causing acute respiratory infections. While RSV often leads to severe cases in children under two years, severe Covid-19 cases in children are rare. This study analysed 264 hospitalised children (0-12 years) with SARS-CoV‑2 or RSV infections between September 2021 and March 2022. RSV infections were more severe than SARS-CoV‑2 infections: 55% of RSV patients required oxygen therapy compared to 9.5% of SARS-CoV-2 cases (p < 0.001). The duration of oxygen therapy was 2 ± 2.6 days for RSV and 0.3 ± 1.07 days for SARS-CoV‑2. RSV patients required significantly longer O

Indexed as

COVID-19HospitalizationRespiratory Syncytial Virus InfectionsChildChild, PreschoolFemaleHumansInfantInfant, NewbornLength of StayMaleOxygen Inhalation TherapySARS-CoV-2Acute respiratory infections in childrenComparison of RSV and SARS-CoV‑2Comparison of SARS-CoV‑2 variantsRSV in childrenSARS-CoV‑2 in children

Identifiers

PMID40889028

DOI10.1007/s10354-025-01094-8

PMCPMC12568783

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.